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a b s t r a c t
During long bone development and post-natal growth, the cartilaginous model of the skeleton is
progressively replaced by bone, a process known as endochondral ossiﬁcation. In the primary spongiosa,
osteoclasts degrade the mineralized cartilage produced by hypertrophic chondrocytes to generate
cartilage trabeculae that osteoblasts embed in bone matrix. This leads to the formation of the trabecular
bone network of the secondary spongiosa that will undergo continuous remodeling. Osteoclasts are
specialized in mineralized tissue degradation, with the combined ability to solubilize hydroxyapatite and
to degrade extracellular matrix proteins. We reported previously that osteoclasts lacking Dock5 could
not degrade bone due to abnormal podosome organization and absence of sealing zone formation.
Consequently, adult Dock5 / mice have increased trabecular bone mass. We used Dock5 / mice to
further investigate the different functions of osteoclast during endochondral bone formation. We show
that long bones are overall morphologically normal in developing and growing Dock5/ mice. We
demonstrate that Dock5 / mice also have normal hypertrophic cartilage and cartilage trabecular
network. Conversely, trabecular bone volume increased progressively in the secondary spongiosa of
Dock5 / growing mice as compared to Dock5þ /þ animals, even though their osteoclast numbers were
the same. In vitro, we show that Dock5 / osteoclasts do present acidic compartments at the ventral
plasma membrane and produce normal amounts of active MMP9, TRAP and CtsK for matrix protein
degradation but they are unable to solubilize minerals. These observations reveal that contrarily to bone
resorption, the ability of osteoclasts to dissolve minerals is dispensable for the degradation of
mineralized hypertrophic cartilage during endochondral bone formation.
& 2014 Elsevier Inc. All rights reserved.
Introduction
In mammals, endochondral bone formation drives the develop-
ment and growth of long bones, which have an essential function in
supporting body weight and muscle-driven appendicular skeleton
movements. Trabeculae form a complex network of bone spicules
inside the metaphyse region that ensure bone strength. The initial
cartilaginous model of long bones is replaced by true bony matrix
during embryonic development and post-natal growth, through a
process called endochondral ossiﬁcation (Mackie et al., 2011). In the
mouse, the ossiﬁcation process starts around E16.5–E17.5. After
condensation, mesenchymal cells differentiate into proliferative
chondrocytes, which will progress into hypertrophic chondrocytes
(Akiyama et al., 2002; Dao et al., 2012; Ding et al., 2012; Yang et al.,
2003). The latter produce and mineralize hypertorphic cartilage,
mainly composed of collagen X (Drissi et al., 2003; Orimo, 2010;
Shen, 2005; Zheng et al., 2003). They also secrete matrix metallo-
protease 13 (MMP13) that is crucial for endochondral ossiﬁcation
progression (D'Alonzo et al., 2002; Nishimura et al., 2012; Xiong
et al., 2011). MMP13 participates in cartilage degradation around
chondrocytes, allowing both hypertrophy and bioavailability of
various factors that contribute to bone dynamics, including vascular
endothelial growth factor (VEGF) and Receptor Activator of NF
kappa B Ligand (RANKL) (Ortega et al., 2010; Stickens et al., 2004;
Xiong et al., 2011). Consecutively, hypertrophic cartilage is invaded
by blood vessels, osteoblasts, osteoclasts and their precursor cells.
Within the primary spongiosa, osteoclasts degrade the mineralized
hypertrophic cartilage and create a network of cartilage trabeculae
onto which osteoblasts deposit and mineralize the ﬁrst bone
matrix, mainly composed of collagen I and hydroxyapatite. Thus,
resorption of hypertrophic cartilage by osteoclasts is a key event in
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structuring bone trabecular network. Bone trabeculae compose the
secondary spongiosa, which is continuously remodeled by osteo-
clasts and osteoblasts throughout life. Longitudinal bone growth is
therefore dependent on the continuous differentiation of chondro-
cytes and on the progressive replacement of mineralized hyper-
trophic cartilage by bone tissue.
Osteoclasts are the only body cells able to degrade mineralized
matrices, in particular hypertrophic cartilage and bone. Never-
theless, these two mineralized tissues have distinct physico-
chemical properties (Duer et al., 2009; Gupta et al., 2005).
Whether osteoclasts require identical cellular processes to degrade
calciﬁed cartilage or bone is unknown. Osteoclasts are necessary
for hypertrophic cartilage removal and mice lacking osteoclasts
such as RANK / mice have extended hypertrophic cartilage zone
(Dougall et al., 1999; Li et al., 2000). In particular, osteoclast-
secreted enzymes MMP9 (Ortega et al., 2005, 2010; Vu et al., 1998),
Tartrate Resistant Acid Phosphatase (TRAP) (Hayman et al., 1996)
and Cathepsin K (Ctsk) (Boskey et al., 2009; Li et al., 2006; Lotinun
et al., 2013) are needed for this process. But the mineralized
cartilage degradation process may also involve other osteoclast
activities, for instance their extracellular medium acidiﬁcation
function (Ortega et al., 2010).
Bone resorption by osteoclasts occurs inside the sealing zone or
actin ring, a circular osteoclast-speciﬁc adhesion structure made of
densely packed podosomes (Luxenburg et al., 2007). It delineates a
region where the plasma membrane in contact with the bone
differentiates into a rufﬂed border through which the cell provides
important acidic and enzymes secretions (Vaananen et al., 2000).
The integrity of the sealing zone is crucial for osteoclasts to acidify
the extracellular medium in contact with the bone, a process that
results in the dissolution of hydroxyapatite crystals. This is a
prerequisite to render bone matrix proteins amenable for degra-
dation by osteoclastic enzymes MMP9, TRAP and CtsK. On the
other hand, it remains unknown whether osteoclasts also need to
acidify the extracellular medium to ensure the degradation of the
matrix proteins of mineralized hypertrophic cartilage (Ortega
et al., 2010).
We sought to investigate the importance of osteoclast sealing
zone during long bone development and growth. We reported
previously that in the absence of Dock5, an activator of the GTPase
Rac, osteoclasts are unable to organize podosomes into a sealing
zone. As a consequence, Dock5 / osteoclasts are unable to resorb
bone ex vivo. Adult Dock5 / mice consistently show increased
trabecular bone volume, even though their osteoclast number is
similar to that of Dock5þ /þ mice. Apart from their bone pheno-
type, adult Dock5 / mice look indistinguishable from wild type
animals and breed normally (Vives et al., 2011). We took advan-
tage of this model to study how osteoclasts lacking the sealing
zone impact on long bone formation and growth. We ﬁrst
observed that the overall bone growth is similar in Dock5þ /þ
and Dock5 /animals. We found that Dock5 / mice have normal
hypertrophic chondrocyte zone and cartilage trabecular network
indicating that their osteoclasts can support calciﬁed hypertrophic
cartilage degradation in the primary spongiosa. Osteoclast density
is comparable between the two genotypes, but we observed that
Dock5 / mice have higher trabecular bone mass in the secondary
spongiosa, where osteoclasts have to degrade bone matrix. We
show that Dock5 / osteoclasts are unable to dissolve CaP crystals,
even though intracellular acidic compartments are present at their
ventral plasma membrane. We ﬁnally found that Dock5 / osteo-
clasts secrete normal levels of MMP9, TRAP and CtsK to degrade
matrix proteins. Taken together, our study reveals that hyper-
trophic cartilage and bone degradation involve distinct osteoclast
activities, the former not requiring the formation of the sealing




Dock5 / mice were described previously (Laurin et al., 2008;
Vives et al., 2011). Mice used in this study were in the mixed
129SvC57Bl/6J background backcrossed to C57Bl/6J for 4 genera-
tions. Dock5þ /þ and Dock5 / mice were obtained by breeding
Dock5þ / animals and maintained in the animal facilities of the
CNRS in Montpellier, France. Procedures involving mice were
performed in compliance with local animal welfare laws, guide-
lines and policies, according to the rules of the regional ethical
committee. Mouse samples contain animal of both sexes, com-
bined at unknown quantities.
Antibodies and reagents
Monoclonal antibodies against CtsK (sc48353), MMP13
(sc80200) and polyclonal antibodies to TRAP (sc28024) and Rab7
(sc10676) were from Santa Cruz Biotechnology. Other antibodies
were as follow: monoclonal anti-βactin (A-5441, Sigma Aldrich)
and polyclonal anti-MMP9 (AF909, R&D Systems). Alexa Fluor 488-
or 546-conjugated secondary antibodies, Alexa Fluor 633-
conjugated Phalloidin and LysoTracker Red DND-99 were from
Invitrogen. All chemicals were from Sigma Aldrich unless other-
wise speciﬁed.
Production of osteoclasts
Bone marrow cells were isolated from long bones of 6- to 8-
week-old mice as described previously (Brazier et al., 2006).
Brieﬂy, non-adherent bone marrow cells were cultured for 2 days
in αMEM (Lonza) containing 10% heat-inactivated fetal calf serum
(FCS, Hyclone) and 2 mM glutamine, supplemented with 30 ng/ml
M-CSF (Peprotech) and used as bone marrow-derived macro-
phages (BMMs). For osteoclast differentiation, BMMs were further
cultured in differentiation medium (αMEM containing 10% heat-
inactivated FCS and 2 mM glutamine, supplemented with 30 ng/
ml M-CSF and 100 ng/ml RANKL (Peprotech)). Differentiation
medium was changed every other day. Osteoclasts generally
appeared after 3 to 5 days. Alternatively, BMMs were maintained
in M-CSF only as a control for undifferentiated cells.
Hypertrophic cartilage matrice
Chondrogenic ATDC5 cells (kindly provided by Laurent Beck
and Jérôme Guicheux, INSERM, Nantes, France) were cultured in
proliferation medium (DMEN F-12 (Lonza) containing 10% fetal
bovine serum (FBS, Hyclone), 1% insulin transferrin and selenium
(ITS), and 2.2 g/l sodium bicarbonate) for 3 weeks in a humidiﬁed
5% CO2 incubator at 37 1C. The medium was replaced every other
day. On day 21 and during 4 weeks, chondrocytes were cultured in
differentiation medium (αMEM containing 10% FBS, 2 mM gluta-
mine, 1% ITS, 2.2 g/l sodium bicarbonate, 0.5% amino acids supple-
mented with 10 mM β-glycerophosphate and 50 mg/ml L-ascorbic
acid) in a humidiﬁed 3% CO2 incubator at 37 1C, to facilitate
mineralization in culture. Medium was changed every day. Then,
the hypertrophic cartilage matrix, synthetized by hypertrophic
chondrocytes, was decellularized with 15 mM ammonium hydro-
xide aqueous solution for 15 min at 37 1C before receiving osteo-
clasts differentiated on plastic dishes for enzymatic activity
analyses. 500 mm femur slices from 4-week old rats (a generous
gift from Luc Malaval and Bernard Laroche, INSERM, Jean Monnet
University, Saint Etienne, France) were obtained using a Buehler
Isomet 11–1180 low speed saw (Buehler, Lake Bluff, Il, USA) set
with a 0.4 mm diamond disk, and collected in 9% NaCl. Bone slices
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were ﬁxed in ethanol for 5 min, rinsed in sterile PBS and stored at
4 1C until used.
Total femur staining
Femurs from E17.5, and P1 to P35 mice were ﬁxed in 70%
ethanol (EtOH) aqueous solution for 24 h, dehydrated in 96% EtOH
aqueous solution during 2 h, incubated in acetone for 2 days,
stained in 2% Alizarin Red S, 6% alcian blue, 5% acetic acid and 70%
EtOH aqueous solution for 3 days at 37 1C in the dark and then
clariﬁed in 1% potassium hydroxide aqueous solution during 12–
48 h.
Histology and immunohistochemistry
Femurs from E17.5, and P1 to P35 mice were ﬁxed for 2 days in
PBS containing 4% paraformaldehyde (Electron Microscopy
Sciences) and 40% EtOH and dehydrated as above. In the case of
P4 to P35 mice, femurs were decalciﬁed in 10% EDTA buffer for 3–5
days. Bones were then embedded in Histowax parafﬁn (Histolab).
Alternatively, ﬁxed and dehydrated femurs from P7 to P35 mice
were embedded undecalciﬁed in historesin under vacuum, using
Historesin embedding kit according to manufacturer's instructions
(Leica). After parafﬁn removal, 6 mm sections were rehydrated and
stained with Safranin O (Diapath) and fast green, Von Kossa,
Goldner's trichrome or TRAP (Tartrate Resistant Acid Phosphatase)
staining solutions. 6 mm historesin sections were stained directly
with Von Kossa solution or for TRAP activity. Brieﬂy, for aqueous
solution staining of cartilaginous glycosaminoglycans by safranin
and bone collagen I by fast green, sections were soaked in 0.1%
safranin during 5 min, rinsed with 70% EtOH, stained in 0.1% fast
green during 30 min then rinsed with distilled water. For Gold-
ner's trichrome staining in aqueous solution, sections were soaked
in 0.075% xylidine ponceau, 0.025% acid fuchsin (Fluka), 0.01%
azophloxin and 2% acetic acid during 15 min, rinsed with 1% acetic
acid for 1 min, stained in 2% Orange G and 4% phosphomolybic
acid during 3 min, rinsed in 1% acetic acid for 2 min, stained in
0.2% light green and 0.2% acetic acid during 10 min and ﬁnally
rinsed with 1% acetic acid and distilled water. For Von Kossa
staining of mineralized tissues, sections were soaked with 1%
AgNO3 for 5 min, rinsed with distilled water during 10 min,
incubated in sodaformol for 5 min, rinsed with tap water during
10 min, immersed in 5% sodium thiosulfate for 5 min and rinsed
with tap water during 10 min. TRAP activity was revealed by
incubating sections for 1 h at 37 1C in 50 mM sodium tartrate,
0.1 M sodium acetate, 0.06% fast red and 0.01% Naphtol AS-MX
Phosphate in N-N-dimethylformamid. Von Kossa and TRAP-
labeled sections were counterstained with 1% alcian blue aqueous
solution containing 3% acetic acid for 3 min and rinsed in distilled
water.
For immunohistochemistry, antigenic sites were unmasked by
incubation of deparafﬁnized sections in pH6 Citrate buffer (Dia-
path) for 30 min at 99 1C. After inhibition of endogenous perox-
idases with 0.3% hydrogen peroxide solution for 20 min, sections
were rinsed in 0.1% Tween in PBS and nonspeciﬁc sites were
blocked with 20% FBS in PBS during 30 min. Antibodies against
MMP9 and MMP13 were used respectively at 1:400 and 1:200 in
PBS containing 1% bovine serum albumin (BSA) for 1 h. Sections
were incubated with the appropriate biotinylated secondary anti-
body diluted 1:333 in PBS containing 1% BSA during 45 min and
then with a signal ampliﬁcation solution of avidin-biotin (Vectas-
tain Elite ABC-Peroxidase kit Standard, Vector) for 30 min. MMP9
and MMP13 were visualized by oxidation of diaminobenzidin
(DAB Peroxidase Substrate Kit, 3,30-diaminobenzidine, Vector).
Sections were counterstained with 0.1% fast green aqueous solu-
tion for 5 min and rinsed in distilled water. All sections were
mounted in Pertex mounting medium (Histolab), except for TRAP
activity staining which was mounted in Aqueous-mount (SkyTek).
Detection of mineral dissolution by osteoclasts
To measure the mineral dissolution activity of osteoclasts,
differentiated Dock5þ /þ and Dock5/ osteoclasts were scrapped
in PBS containing 0.025 mM EDTA and seeded onto inorganic
crystalline calcium phosphate (CaP)-coated multiwells (Osteo
Assay Surface, Corning) for 3 days. In each experiment and for
each genotypes, 4 wells were then stained for TRAP activity to
count osteoclasts and 4 wells with Von Kossa to measure CaP
dissolution as described previously (Brazier et al., 2009).
Detection of acidic compartments and immunoﬂuorescence
Osteoclast differentiation medium was removed and replaced
with fresh medium containing 100 nM LysoTracker Red DND-99 to
reveal intracellular acidic compartments. After 2 h at 37 1C,
Fig. 1. Long bone growth is not affected in Dock5 / mice.(A) Whole femurs of the
indicated stages between E17.5 and P35, stained for cartilage glycosaminoglycans
with alcian blue (blue) and for calciﬁed tissue with alizarin red (purple). Scale bar in
E17.5 Dock5þ /þ¼4 mm. (B) Bar graph shows average and SEM length of Dock5þ /þ
and Dock5 / femurs at indicated developmental stages. Sample size (Dock5þ /þ/
Dock5 /): E17.5 (3/6); P1 (3/4); P4 (4/6); P7 (4/4); P15 (4/6); P21 (5/5); and
P35 (4/3).
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osteoclasts were washed with PBS and placed in fresh differentia-
tion medium for live-microscopy analysis. Indirect immunoﬂuor-
escence was performed after ﬁxation of the cells with 3.7%
formalin in PBS for 10 min, permeabilization with 0.1% Triton X-
100 in PBS for 5 min and saturation with 2% BSA in PBS, followed
by incubation with primary antibodies: polyclonal anti-Rab7 and
monoclonal anti-Vinculin respectively used at 1:50 and 1:400 in
PBS containing 2% BSA during 1 h. After three washes in PBS,
primary antibodies were revealed with Alexa Fluor 488-
conjugated goat anti-rabbit and 546-conjugated goat anti-mouse
antibodies. Alexa633-conjugated phalloidin was used to reveal
F-actin and cells were mounted in CitiFluor mounting medium
(Biovalley).
Detection of secreted enzymes
Culture supernatants of Dock5þ /þ and Dock5 / BMMs and
mature osteoclasts grown on glass coverslips, bone slices
(DT1BON100096, IDS) or ATDC5 cell-derived hypertrophic carti-
lage were collected to measure the activity of secreted enzymes.
To reveal active MMP9, cells were cultured in αMEM medium
containing 2% heat-inactivated FCS during 6 h. Supernatants were
then collected and loaded on a 10% Zymogram gelatin gel (NOVEX,
Invitrogen). Gelatinase activity of MMP9 was revealed according to
manufacturer's instructions. Detection of the active forms of TRAP
and CtsK in culture supernatants was performed by western blot
using the polyclonal anti-TRAP and the monoclonal anti-CtsK
antibodies at 1:500 in TBS containing 2% BSA. Cell lysates were
used as loading controls and analyzed by western blot with the
monoclonal anti-βactin at 1:5000 in TBS containing 2% BSA.
Culture supernatants and cell extracts were prepared in Laemmli
sample buffer, resolved by SDS-PAGE and electrotransferred on
nitrocellulose membranes. Immunoblotting was performed and
signals were revealed using the ECL Western Lightning Plus
detection system (Perkin Elmer) with horseradish peroxidase-
conjugated secondary antibodies (GE Healthcare), according to
manufacturer's instructions.
Microscopic and binocular imaging
Multiwells coated with crystalline inorganic CaP stained with Von
Kossa solution and living osteoclasts labeled with LysoTracker Red
Fig. 2. Hypertrophic chondrocyte length is normal in Dock5 / mice. (A) Safranin staining (orange) of parafﬁn-embedded femurs sections from Dock5þ /þ and Dock5 /
mice between E17.5 and P35. Dashed lines delineate hypertrophic cartilage zone. Scale bar in E17.5 Dock5þ /þ¼200 mm. (B) Bar graph shows average and SEM length of
hypertrophic chondrocytes zone in femurs from Dock5þ /þ and Dock5 / mice at indicated developmental stages. Sample size (Dock5þ /þ/Dock5 /): E17.5 (3/3); P1 (3/3);
P4 (3/3); P7 (5/3); P15 (7/6); P21 (7/6); and P35 (4/3).
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were imaged using a Zeiss Axio Imager Z1 microscope with Cool-
SNAP color Cf camera (Photometrics, Molecular Devices) or Micro-
Max camera (Princeton Instruments) respectively. Videos were taken
at 5-min intervals during 95 min and stacks were generated with
ImageJ 1.42 software. Histological sections were imaged with a Zeiss
Axio Imager Z2 microscope with CoolSNAP color Cf camera (Photo-
metrics, Molecular Devices). Indirect immunoﬂuorescences were
imaged using an SP5-SMD confocal microscope (Leica), each channel
was imaged sequentially using the multitrack recording module
before merging to ensure only one ﬂuorochrome was detected at a
time. Images were acquired with MetaMorph 7.7.6 software. Whole
bones and TRAP stained osteoclasts on CaP multiwell devices were
imaged with a Nikon SMZ 1000 binocular with Nikon DXM 1200F
camera under Nikon ACT-1 2.7 software.
Histomorphometry
Histomorphometry was performed with BioQuant Osteo II
12.1.6 software.
The cartilage trabecular network was deﬁned as the zone
immediately located below the hypertrophic chondrocytes,
composed only of mineralized cartilage trabeculae and bone
marrow. The height of this region for both genotypes was
120 mm (P7), 120 mm (P15), 140 mm (P21) or 150 mm (P35). The
secondary spongiosa that contains only bone-coated trabeculae
was deﬁned for each stage, starting at 300 mm (P7), 320 mm (P15),
350 mm (P21) or 400 mm (P35) away from the growth plate,
avoiding the cortical structures, and with a height of 1200 mm
(P7), 1600 mm (P15), 1900 mm (P21) or 2500 mm (P35). For global
cartilage and bony trabecular network, the region considered
extended form the top of the cartilage trabecular network down
to the bottom of the secondary spongiosa as deﬁned above. For
earlier stages, the height of this regionwas 700 mm (E17.5), 900 mm
(P1) and 1000 mm (P4)
All histological measures were done double blind on three
different sections per animal.
Quantiﬁcation methods and statistical analyses
Measurements of bone and protease expression region lengths,
resorbed areas, immunohistochemistry staining and western blot
densitometry analyses were performed with Image J 1.42 software.
Fig. 3. MMP13 is normally expressed and localized in Dock5 / mice. (A) MMP13 immunostaining (brown staining between dashed lines) of parafﬁn-embedded femurs
sections from Dock5þ /þ and Dock5 / mice between E17.5 and P35. Scale bar in E17.5 Dock5þ /þ¼200 mm. (B) Bar graph shows average and SEM length of MMP13 zone in
femurs from Dock5þ /þ and Dock5 / mice at indicated developmental stages. Sample size (Dock5þ /þ/Dock5 /): E17.5 (3/3); P1 (3/3); P4 (3/3); P7 (3/3); P15 (7/3); P21
(7/3); and P35 (4/3).
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Statistical signiﬁcance was determined using Mann–Whitney
nonparametric test.
Results
Dock5 is dispensable for long bone growth
Mice with osteoclasts defective for sealing zone formation can
be either small with short limbs and thickened growth plates such
as Src/ mice (Soriano et al., 1991) or of normal stature such as
Vav3 / mice (Faccio et al., 2005). Thus, we analyzed the impact
of Dock5 on long bone development and growth. Staining of whole
bone mineralized tissues and of cartilage glycosaminoglycans and
mucopolysaccharides did not reveal any major defects in the
ossiﬁcation process of long bones in Dock5 / mice at E17.5
and P1, 4, 7, 15, 21 and 35 days of post-natal development
(Fig. 1A) and femur size was not signiﬁcantly different between
Dock5þ /þ and Dock5 / mice at any stage (Fig. 1B).
These data suggest that the overall process of bone mineraliza-
tion and longitudinal growth is not affected in Dock5 / mice,
whose osteoclasts lack sealing zones.
Dock5 is not necessary for hypertrophic cartilage structuration
The absence of osteoclasts results in the increase in length of the
hypertrophic chondrocyte zone, as shown for instance in RANK /
mice (Dougall et al., 1999; Li et al., 2000). In Dock5/ mice,
osteoclasts can differentiate but they are unable to assemble their
podosomes into a sealing zone (Vives et al., 2011). To investigate a
potential impact on hypertrophic cartilage, we analyzed the main
characteristics of this tissue: the length of the hypertrophic chondro-
cytes zone, the localization of MMP13 expression and its mineraliza-
tion status on femur sections of Dock5þ /þ and Dock5 / mice
between E17.5 and P35 (Figs. 2–4). Glycosaminoglycan staining with
safranin did not reveal any difference in hypertrophic cartilage
organization between the two genotypes at any stage (Fig. 2A). In
particular, the length of the hypertrophic chondrocytes zone was
identical in Dock5þ /þ and Dock5 / mice (Fig. 2B). The immunohis-
tochemical staining of MMP13 (Fig. 3A), which is secreted by the
hypertrophic chondrocytes, revealed that its expression pattern was
also similar between the two genotypes (Fig. 3B). Finally, Von Kossa
staining showed no difference in hypertrophic cartilage mineralization
between Dock5þ /þ and Dock5 / mice (Fig. 4A, B).
Fig. 4. Hypertrophic cartilage is mineralized properly in Dock5 / mice. (A) Von Kossa staining (black) of parafﬁn-embedded (E17.5 and P1) or historesin-embedded
(P7, P15, P21 and P35) femurs sections from Dock5þ /þ and Dock5 / mice. Dashed lines delineate hypertrophic cartilage zone. Scale bar in E17.5 Dock5þ /þ¼200 mm. (B) Bar
graph shows average and SEM mineralized volume/total volume (MV/TV) in hypertrophic cartilage of femurs from Dock5þ /þ and Dock5 / mice at indicated developmental
stages. Sample size (Dock5þ /þ/Dock5 /): E17.5 (3/3); P1 (3/3); P7 (4/4); P15 (4/4); P21 (5/4); and P35 (4/4).
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Taken together, these results show that the structure and miner-
alization of hypertrophic cartilage is normal in Dock5 / mice.
Bone but not cartilage trabecular network is altered in Dock5 /
mice
We reported previously that adult Dock5 / mice have increased
trabecular bone volume as compared to wild type (Vives et al., 2011).
To determine when and where this difference arises during develop-
ment and growth, we compared the evolution of the global bony and
cartilage trabecular networks between E17.5 and P35 in Dock5þ /þ
and Dock5/ mice. Histomorphometry analyses after Goldner's
trichrome staining of femur slices (Fig. 5A) showed that the trabecular
volume was not affected by the absence of Dock5 until P4 (Fig. 5B).
Interestingly at P7, Dock5/ mice started showing signiﬁcant higher
trabecular volume as compared to Dock5þ /þ animals, which was
maintained throughout bone growth (Fig. 5B).
To further understand the mechanism leading to increased
bone volume in Dock5 / mice, we next examined the evolution
of osteoclast density between E17.5 and P35. TRAP staining of
femur sections (Fig. 6A) showed no signiﬁcant difference in
osteoclast numbers per bone perimeter between Dock5þ /þ and
Dock5/ mice (Fig. 6B). This suggests that the increase of
trabecular bone volume arising in Dock5/ mice from P7 is not
due to a reduction in osteoclast numbers.
During bone development, degradation of hypertrophic carti-
lage by osteoclasts leads to the formation of cartilaginous trabe-
culae, which serve as templates for the deposition of the ﬁrst bone
matrix that will then be remodeled. To determine more precisely
where the increase in trabecular volume occurs in Dock5 / mice,
Fig. 5. Global trabecular volume increases from P7 in Dock5 / mice. (A) Goldner's trichrome staining of parafﬁn-embedded femurs sections from Dock5þ /þ and Dock5 /
mice between E17.5 and P35. Scale bars in Dock5þ /þ¼200 mm. (B) Bar graph shows average and SEM trabecular bone volume/total volume (BV/TV) in femurs from Dock5þ /þ
and Dock5 / mice at indicated developmental stages. Sample size (Dock5þ /þ/Dock5 /): E17.5 (3/3); P1 (3/3); P4 (3/3); P7 (7/7); P15 (8/7); P21 (8/8); and P35 (8/7).
nPo0.05, nnPo0.01, nnnPo0.001, Mann–Whitney test.
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we analyzed the geometry of cartilage and bone trabecular net-
works independently. We performed histomorphometry on P7,
P15, P21 and P35 femur sections stained with a safranin/fast green
solution to discriminate cartilage from bone (Fig. 7A). In the area of
the primary spongiosa where only cartilage trabeculae are present
(between dashed lines in Fig. 7A), histomorphometry analyses
showed that the mineralized cartilage tissue volume, trabecular
number, thickness and spacing were not signiﬁcantly different
between Dock5þ /þ and Dock5 / mice (Fig. 7B). Conversely, in
the secondary spongiosa where bone coats the surface of trabe-
culae, trabecular bone volume was higher in Dock5/ mice as
compared to Dock5þ /þ mice at all stages, with signiﬁcantly higher
trabecular number and thickness and decreased trabecular separa-
tion (Fig. 7C).
These data indicate that the degradation of hypertrophic
mineralized cartilage, which leads to the formation of the cartilage
pattern of bone trabeculae, is not affected in Dock5/ mice, even
though their osteoclasts cannot assemble sealing zones. By con-
trast, histomorphological differences arise in the secondary spon-
giosa where bone degradation is involved. This suggests that the
mechanisms of mineralized cartilage degradation by osteoclasts
may be different from those involved in bone resorption.
Impaired mineral dissolution but normal acidic compartment
localization and active enzyme secretion in Dock5 / osteoclasts
Bone resorption sequentially requires the acidic dissolution of
its mineral components and the enzymatic digestion of its organic
components (Vaananen et al., 2000). We further examined these
two functions in cultured wild type and Dock5/ osteoclasts
seeded on different types of substrates.
Fig. 6. Osteoclast density is normal in Dock5 / mice. (A) Osteoclasts TRAP staining (red) of parafﬁn-embedded (E17.5 and P4) or historesin-embedded (P7, P15, P21 and
P35) femurs sections from Dock5þ /þ and Dock5 / mice. Scale bars in Dock5þ /þ¼200 mm. (B) Bar graph shows average and SEM osteoclasts number per bone perimeter
(Nb.OC/B.Pm) in femurs from Dock5þ /þ and Dock5 / mice at indicated developmental stages. Sample size (Dock5þ /þ/Dock5 /): E17.5 (3/3); P1 (3/3); P4 (3/3); P7 (7/7);
P15 (7/7); P21 (8/8); and P35 (8/7).
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To study the ability of osteoclasts to dissolve minerals, we
seeded osteoclasts onto pure crystal CaP substrate. After 3 days,
Von Kossa staining of the matrix and TRAP staining of osteoclasts
showed very few mineral dissolution areas (Fig. 8A), indicating
that Dock5 / osteoclasts are severely impaired for extracellular
medium acidiﬁcation (Bar graph in Fig. 8A). To identify the origin
of this defect, we followed ﬂuorescent labeled lysosomal and late
endosomal acidic compartments in live osteoclasts under a video
microscope, which revealed the presence of acidic vesicles in both
Dock5þ /þ and Dock5/ osteoclasts (Fig. 8B, Movies 1 and 2).
Fig. 7. Normal cartilage trabecular network but increased trabecular bone mass in Dock5 / mice. (A) Safranin staining (orange) to detect cartilage glycosaminoglycans, and
fast green staining (blue) for the detection of bone collagen I, of parafﬁn-embedded femurs sections from Dock5þ /þ and Dock5 / mice between E17.5 and P35. Lower panels
are magniﬁcations of the boxed areas in the upper panels and dashed lines delineate the calciﬁed cartilage trabecular network within the primary spongiosa, where no bone
apposition has occurred. Scale bars in Dock5þ /þ¼200 mm. (B, C) Bar graphs show average and SEM mineralized volume/total volume (MV/TV), bone volume/total volume
(BV/TV), trabecular number (Tb, N), trabecular thickness (Tb, Th) and trabecular spacing (Tb, Sp) in (B) calciﬁed cartilage trabecular network and in (C) the secondary
spongiosa of femurs from Dock5þ /þ and Dock5 / mice at indicated developmental stages. Sample size (Dock5þ /þ/Dock5 /): P7 (8/7); P15 (8/7); P21 (8/8); P35 (7/7).
nPo0.05, nnPo0.01, nnnPo0.001, Mann–Whitney test.
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Fig. 8. Altered mineral dissolution function but correct ventral plasma membrane localization of intracellular acidic compartments in Dock5 / osteoclasts. (A) Crystalline
inorganic CaP-coated multiwells stained with Von Kossa solution (left panels) or for TRAP activity (right panels) after a 3 day-incubation with Dock5þ /þ and Dock5 / osteoclasts.
White areas reveal mineral dissolution by osteoclasts. Scale bars in Dock5þ /þ¼1 mm. Bar graph shows average and SEM areas of mineral dissolution by Dock5þ /þ and Dock5 /
osteoclasts from 4 wells. This experiment is representative of 3. *Po0.05, Mann–Whitney test. (B) Dock5þ /þ and Dock5 / live osteoclasts differentiated on glass coverslips,
incubated for 2 h in 100 nM LysoTracker Red (red) and imaged by light modulation contrast (LMC) and ﬂuorescence microscopy (Lysotracker). Right images (Merged) show
superimposition of LMC and Lysotracker images. Scale bar in LMC Dock5þ /þ¼30 mm. (C–F) Rab7 (green), vinculin (red) and actin (blue) staining of osteoclasts seeded on glass
coverslips (C), bone slice (D) or hypertrophic cartilage (E, F). Lower (C–E) and right (F) panels showmagniﬁcation of the merged boxed areas from upper or left panels respectively.
Scale bar in Rab7 Dock5þ /þ¼30 mm.
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We then performed immunoﬂuorescence on ﬁxed osteoclasts with
Rab7 antibodies to label lysosomes and late endosomes. Costain-
ing of vinculin and actin was done to visualize podosomes and
locate the focal plan of the ventral plasma membrane (Fig. 8C–F).
In Dock5þ /þ osteoclasts seeded on glass coverslips or on bone
slices, Rab7-labeled acidic compartments localized both within
and outside the podosome belt or the sealing zone respectively
(Fig. 8C, D, left panels). In Dock5 / osteoclasts, acidic compart-
ments were similarly present at the ventral plasma membrane,
even though these osteoclasts do not form podosome belts or
sealing zones (Fig. 8C, D, right panels). On calciﬁed cartilage, Rab7
staining was also present at the ventral plasma membrane of both
Dock5þ /þ and Dock5 / osteoclasts (Fig. 8E). Interestingly, actin
and vinculin staining did not reveal any organization reminiscent
of a sealing zone in wild type osteoclasts seeded on calciﬁed
cartilage (Fig. 8E, F).
These results suggest that the sealing zone is essential to
dissolve pure CaP matrices but not for intracellular acidic com-
partment formation and transport to the ventral plasma mem-
brane. Moreover, osteoclasts seeded on calciﬁed hypertrophic
cartilage do not appear to form sealing zones.
We next examined the status of the MMP9, TRAP and CtsK, the
main osteoclastic enzymes involved in endochondral ossiﬁcation.
Zymography analysis of MMP9 activity released by Dock5þ /þ and
Dock5 / osteoclasts seeded on glass, bone or ATDC5-derived
hypertrophic cartilage showed no effect of the osteoclast genotype
whatever the culture substrate (Top lanes and right bar graphs in
Fig. 9A–C). Similarly, western blot analysis showed no difference in
the levels of secreted active forms of TRAP and Ctsk (Fig. 9A–C).
These results show that Dock5 / osteoclasts, which are
unable to form sealing zones, are defective for extracellular
medium acidiﬁcation but remain competent for the secretion of
the active enzymes involved in matrix degradation.
Within long bones, MMP9 is produced by osteoclasts and as
well as by non-osteoclastic cells (Ortega et al., 2010). The labeling
of MMP9 on parafﬁn-embedded femur sections revealed identical
distribution of MMP9 in Dock5þ /þ and Dock5 / mice between
E17.5 and P35 (Fig. 9D).
Taken together, these data demonstrate that Dock5/ osteo-
clasts are defective for the dissolution of minerals while present-
ing normal acidic compartments at the plasma membrane and
active enzymes production.
Discussion
In this study, we addressed the importance of osteoclast
mineral dissolution function during long bone development and
growth. We used the Dock5 / mice model, whose osteoclasts
cannot assemble sealing zones and are unable to resorb bone. We
show that Dock5 / osteoclasts secrete active MMP9, TRAP and
CtsK to normal levels. Their intracellular acidic compartments also
appear normal but Dock5 / osteoclasts are unable to dissolve
CaP. With this model, we could speciﬁcally explore the conse-
quences of defective acidiﬁcation of the extracellular medium by
osteoclasts during bone development and growth. We found that
these processes are overall normal in Dock5/ mice. Still, we
observed increased trabecular volume of long bones in Dock5 /
mice, starting at P7 and maintaining throughout bone growth.
Interestingly, precise histomorphometry analyses revealed that
the cartilaginous and bony trabecular networks are differently
affected by Dock5 knock down. On one hand, the structure and
morphological parameters of pure cartilaginous trabecular net-
work beneath the hypertrophic chondrocyte zone, which arises
from the degradation of calciﬁed cartilage by osteoclasts, are
indistinguishable between Dock5þ /þ and Dock5 / mice. On the
other hand, the bony trabecular network of the secondary spon-
giosa shows increased bone mass in Dock5 / mice. Taken
together, our data show that Dock5 / osteoclasts can fulﬁll the
degradation of hypertrophic cartilage, even though they are
unable to dissolve minerals. These results further suggest that
the extracellular medium acidiﬁcation function of osteoclasts,
which requires the formation of the sealing zone, is dispensable
for the removal of hypertrophic cartilage during endochondral
bone formation.
During endochondral ossiﬁcation, osteoclasts are needed for
the degradation of the mineralized cartilage secreted by hyper-
trophic chondrocytes. This removes the transverse septa and
leaves vertical septa remnants that provide a scaffold for osteo-
blasts to deposit the ﬁrst bone matrix. Thereby, hypertrophic
cartilage leftovers that result from the degrading activity of
osteoclasts will further deﬁne the geometry of the trabecular bone
network (Mackie et al., 2011). As a consequence, mice lacking
osteoclasts show strong increase in hypertrophic cartilage length
as in the case of RANK/ mice (Dougall et al., 1999; Li et al.,
2000). In particular, the degradation of hypertrophic cartilage
requires secretion of MMP9, TRAP and CtsK by osteoclasts to
ensure normal development and growth of long bones. In fact,
abnormal removal of calciﬁed cartilage in mice deﬁcient for MMP9
(Ortega et al., 2005, 2010; Vu et al., 1998), for Acp5, which encodes
TRAP (Hayman et al., 1996), or for CtsK (Boskey et al., 2009;
Video S1. Movie 1 (Related to Figure 8B) – Acidic compartment detection in live
Dock5þ /þ and Dock5 / osteoclasts. Time-laps imaging of live Dock5þ /þ (Movie
1) osteoclasts differentiated on glass coverslips and incubated for 2 h with 100 mM
Lysotracker Red to visualized acidic compartments. Video images were taken every
5 min for 95 min. Scale bar ¼30 mm. This experiment is representative of 2.
Supplementary material related to this article can be found online at http://dx.
doi.org/10.1016/j.ydbio.2014.06.020.
Video S2. Movie 2 (Related to Figure 8B) – Acidic compartment detection in live
Dock5 / (Movie 2) osteoclasts. Time-laps imaging of live Dock5þ /þ (Movie 2)
osteoclasts differentiated on glass coverslips and incubated for 2 h with 100 mM
Lysotracker Red to visualized acidic compartments. Video images were taken every
5 min for 95 min. Scale bar ¼30 mm. This experiment is representative of 2.
Supplementary material related to this article can be found online at http://dx.
doi.org/10.1016/j.ydbio.2014.06.020.
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Fig. 9. Enzymatic activity is normal in Dock5 / osteoclasts. (A-C) Zymograph and western blot detection of enzymes secreted by cultured Dock5þ /þ and Dock5 / osteoclasts. In A,
B: Dock5þ /þ and Dock5 / BMMs were cultured for 4 days in the absence (-) or in the presence of RANKL (Rþ) on (A) glass coverslips or (B) bone slices. C: Dock5þ /þ and Dock5 /
osteoclasts were differentiated on ATDC5 cell-derived hypertrophic cartilage (HC) or on glass coverslips (G). In the osteoclast culture supernatants, secreted MMP9 activity (95 kDa)
was monitored by zymography and active forms of TRAP (23 kDa) and CtsK (30 kDa) were detected by western blot. Bar graphs show average and SEM activities normalized to ß-actin
levels in the corresponding whole cell lysates from 3 (A, B) or 2 (C) independent experiments. (D) MMP9 immunostaining (brown staining between dashed lines) of parafﬁn-
embedded femurs sections from Dock5þ /þ and Dock5 / mice between E17.5 and P35. Scale bar in E17.5 Dock5þ /þ¼200 mm. Sample size (Dock5þ /þ / Dock5 /): E17.5 (3/3);
P1 (3/3); P4 (3/3); P7 (3/3); P15 (7/3); P21 (7/3); P35 (4/3).
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Li et al., 2006; Lotinun et al., 2013) result in extended hypertrophic
cartilage zone and consequently in abnormal endochondral ossi-
ﬁcation. Interestingly, we show here that Dock5 / osteoclasts,
seeded on glass, bone or hypertrophic cartilage, secrete normal
levels of active MMP9, TRAP and CtsK. In Dock5 / mice, the
hypertrophic chondrocyte zone is organized and mineralized
normally. The morphological parameters of cartilage trabeculae
within the primary spongiosa are the same in the two genotypes.
This suggests that the mineral dissolution function of osteoclasts,
which is deﬁcient in Dock5 / animals, is not necessary for the
degradation of calciﬁed hypertrophic cartilage, contrarily to the
degradation of bone. Consistently, in the secondary spongiosa
where trabeculae are coated with bony matrix and bone remodel-
ing occurs, Dock5 / mice show higher trabecular number and
thickness and reduced trabecular spacing, reﬂecting the inability
of their osteoclasts to resorb bone.
It is well established that osteoclasts cannot degrade bone
matrix proteins without their prior acidic dissolution of hydro-
xyapatite (Vaananen et al., 2000). Conversely, our results suggest
that osteoclast proteases can efﬁciently remove calciﬁed cartilage
without prior demineralization. Different mineralization levels of
bone and cartilage could account for this differential requirement
of mineral dissolution before collagen ﬁber proteolysis. Indeed, in
rachitic FGF23 transgenic mice where bone mineral density is
reduced, osteoclasts secrete normal levels of MMP9 and Ctsk and
they can degrade bone even though they do not exhibit sealing
zones (Hollberg et al., 2008). Nevertheless, it was shown that bone
and calciﬁed cartilage show similar calcium contents, but that for a
given mineral content, bone is stiffer that cartilage, suggesting a
distinct organization of minerals in the collagen ﬁbrils (Gupta
et al., 2005). In fact, the level of hydratation of cartilage is higher
than that of bone, which results in lower connection between
mineral and matrix proteins in cartilage as compared to bone
(Duer et al., 2009). The looser interaction of minerals with the
collagen ﬁbers could make them amenable to enzymatic degrada-
tion without prior demineralization. In contrary in the bone, the
removal of hydroxyapatite, which is tightly connected to collagen
ﬁbers, is a prerequisite for their proteolysis. Bone resorbing
osteoclasts assemble their podosomes into a dense ring to form
the sealing zone, which enables the formation of the rufﬂe border.
The sealing zone allows the conﬁnement of the chloride ions and
protons released at the rufﬂed border, leading to extracellular
medium acidiﬁcation at the bone surface (Baron et al., 1985).
Interestingly, various electron micrograph studies revealed that
osteoclasts sitting on cartilage in vivo, also named chondroclasts,
do not have a rufﬂed border whether the cartilage is mineralized
or not (Nordahl et al., 1998; Ota et al., 2009; Yamazaki and Sasaki,
2005). In line with this observation, we did not observe sealing
zones in wild type osteoclasts cultured on mineralized cartilage.
Taken together, these observations suggest that secretion of active
proteases is sufﬁcient, and mineral removal dispensable, to ensure
efﬁcient calciﬁed cartilage degradation by osteoclasts.
In apparent contradiction with this hypothesis, severe bone
phenotypes including hypertrophic zone enlargement and shorter
bone due to defective cartilage degradation were reported in mice
mutant for CLCN7, enconding the chloride channel ClC-7 or for
TCIRG1, encoding the a3 subunit of the vacuolar-type ATPase
(V-ATPase) (Kornak et al., 2001; Neutzsky-Wulff et al., 2010;
Schinke et al., 2009; Seifert and Marks, 1985). ClC-7 and V-
ATPase play a central role in bone resorbing osteoclasts by
pumping out chloride ions and protons at the rufﬂe border to
acidify the extracellular medium in contact with bone (Baron et al.,
1985; Kornak et al., 2001). But these proteins are also essential for
intracellular lysosome acidiﬁcation (Ruivo et al., 2009), which
participates in the activation of CtsK (Mindell, 2012). Indeed,
ClC-7 and a3 V-ATPase are required for the optimal function of
CtsK to degrade decalciﬁed collagen ﬁbers (Henriksen et al., 2006).
In the case of Dock5 / osteoclasts, we found that acidic compart-
ments and active CtsK secretion were not affected. Interestingly,
we observed that Rab7 staining at the ventral plasma membrane
of Dock5þ /þ osteoclasts seeded on bone was not restricted within
the sealing zone. Furthermore, these osteoclasts sitting on calciﬁed
cartilage did not have sealing zones while Rab7 staining was still
present at the ventral plasma membrane. This suggests that the
assembly of the sealing zone is not a prerequisite for acidic vesicle
targeting towards the substrate to be degraded. Consistently,
Dock5 / osteoclasts seeded on bone presented Rab7-positive
vesicles at their ventral plasma membrane. These differential
effects on intracellular acidic compartments could account for
the defect in hypertrophic cartilage removal and severe bone
phenotypes of ClCN7 and TCIRG1 mutant mice as compared to
Dock5 / mice. The bone phenotype of adult Carbonic Anhydrase
II (CAII)-deﬁcient mice further sustains this hypothesis (Margolis
et al., 2008). CA-II is the primary source of protons for the
v-ATPase (Rousselle and Heymann, 2002) but its inhibition was
shown not to affect the acidiﬁcation of osteoclast lysosomes
(Henriksen et al., 2008). Contrarily to CLCN7 and TCIRG1 deﬁcient
mice, animals lacking CAII exhibit normal formation of the
medullar cavity, suggesting that the removal of hypertrophic
cartilage transverse septae is functional. They also show increased
trabecular bone mass with moderate bone phenotype (Margolis
et al., 2008). This phenotype is consistent with our conclusion that
osteoclasts unable to acidify extracellular medium but not affected
in intracellular compartments acidiﬁcation can support calciﬁed
cartilage degradation.
In conclusion, our study highlights the differential requirement
of extracellular medium acidiﬁcation by osteoclasts for the degra-
dation of mineralized hypertrophic cartilage and for resorbing
bone. It reveals a signiﬁcant biological distinction between the
function of osteoclasts and of the so-called chondroclasts, osteo-
clasts sitting on cartilage, during the process of endochondral bone
formation and bone lengthening. The degradation of hypertrophic
cartilage is essential to establish the future bone trabecular net-
work and the medullar cavity of the growing bones. Defects in its
removal, such as in ClCN7 or TCIRG1 deﬁcient mice and patients,
leads to severe bone growth defects and abnormal formation of
the marrow cavity. In terms of potential medical applications, it
suggests that the development of next generation antiresorptive
treatments, to be used in osteoporotic children for instance, should
aim at targeting the acidiﬁcation function of osteoclasts while
preserving the secretion of proteases intact to have less adverse
effects on long bone growth.
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